Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

Bezie Kebede zelalem, Desalegn Feyisa School of Pharmacy, College of Health Science, Mizan-Tepi University, Mizan-Teferi, EthiopiaCorrespondence: Bezie Kebede zelalem Tel +251 921279910Email beza.kebede21@gmail.comBackground: Diabetes mellitus (DM) is a chronic degenerative disease associated with a...

Full description

Bibliographic Details
Main Authors:	Kebede zelalem B, Feyisa D
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-12-01
Series:	Diabetes, Metabolic Syndrome and Obesity
Subjects:	diabetes statin initiation determinants primary prevention secondary prevention general hospital
Online Access:	https://www.dovepress.com/determinants-of-statin-initiation-among-adult-diabetic-patients-in-bon-peer-reviewed-article-DMSO

Similar Items

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
by: Emily Decicco, et al.
Published: (2023-12-01)

An analysis of the effect of statins on the risk of Non‐Hodgkin's Lymphoma in the Women’s Health Initiative cohort
by: Pinkal Desai, et al.
Published: (2018-05-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
by: Omar Mhaimeed, et al.
Published: (2024-06-01)

Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia
by: Melaku EE, et al.
Published: (2023-11-01)

Cost-effectiveness analysis of statins in primary care: results from the Arteris cohort study
by: Michel Romanens, et al.
Published: (2021-04-01)

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement
by: SHI Weili, LI Mingyan, DUAN Hongyan
Published: (2024-04-01)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
by: Michael M. Hammond, et al.
Published: (2023-04-01)

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
by: Ziv Dadon, et al.
Published: (2021-11-01)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023-03-01)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
by: Thongtang N, et al.
Published: (2020-02-01)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
by: Shu-ting Chen, et al.
Published: (2019-03-01)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01)

Multimorbidity and statin prescription for primary prevention of cardiovascular diseases: A cross-sectional study in general practice in France
by: Racha Onaisi, et al.
Published: (2023-01-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
by: Kritika Prasai, et al.
Published: (2021-03-01)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
by: Ying Xian, et al.
Published: (2019-10-01)

Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
by: Maarit J. Korhonen, et al.
Published: (2020-02-01)

A Prognostic Merit of Statins in Patients with Chronic Hemodialysis after Percutaneous Coronary Intervention—A 10-Year Follow-Up Study
by: Takehiro Funamizu, et al.
Published: (2022-01-01)

Crosstalk between Statins and Cancer Prevention and Therapy: An Update
by: Beniamin Oskar Grabarek, et al.
Published: (2021-11-01)

Healthy lifestyle, statin, and mortality in people with high CVD risk: A nationwide population-based cohort study
by: Wenyao Peng, et al.
Published: (2024-03-01)

Statin Twitter: Human and Automated Bot Contributions, 2010 to 2022
by: Samuel D. Slavin, et al.
Published: (2024-04-01)

Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without <i>Helicobacter pylori</i> Infection
by: Tae Jin Kwon, et al.
Published: (2021-03-01)

Differences in Cardiovascular Care Between Adults With and Without Opioid Prescriptions in the United States
by: Zekun Feng, et al.
Published: (2020-06-01)

Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance
by: S. R. Gilyarevskiy, et al.
Published: (2013-12-01)

STATINS AND THE RISK OF DIABETES MELLITUS
by: O. M. Drapkina
Published: (2015-09-01)

Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care
by: Alvaro Sanchez, et al.
Published: (2022-10-01)

Possible Modification of Alzheimer Disease by Statins in Midlife: Interactions with Genetic and Non-Genetic Risk Factors
by: Mitsuru eShinohara, et al.
Published: (2014-04-01)

Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
by: Alyssa M. B. White, et al.
Published: (2020-11-01)

Statin Utilization Patterns among Type 2 Diabetes Mellitus Patients with High Cardiovascular Disease Risks in Ethiopia
by: Tsegaye Melaku, et al.
Published: (2019-07-01)

National Trends in Statin Use in Lithuania from 2010 to 2021
by: Gytis Makarevičius, et al.
Published: (2022-12-01)

Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial
by: Fabrice Bonnet, et al.
Published: (2020-04-01)

Statins associated diabetes: state of the problem in 2018
by: Zh. D. Kobalava, et al.
Published: (2018-09-01)

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
by: K. Vijayaraghavan, et al.
Published: (2024-01-01)

MĂSURI DE PREVENIRE CARE URMĂRESC REDUCEREA CERERII DE DROGURI ŞI A CONSUMULUI ILICIT DE DROGURI
by: Angela MIRON
Published: (2017-01-01)